Completed
Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin
NCT05581407
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- CEVAC, University Hospital Ghent, Belgium